Allergy Therapeutics (LON:AGY) Stock Rating Reaffirmed by FinnCap

Share on StockTwits

FinnCap reiterated their corporate rating on shares of Allergy Therapeutics (LON:AGY) in a research report report published on Thursday, ThisIsMoney.Co.Uk reports.

Separately, Numis Securities reaffirmed a buy rating and issued a GBX 35 ($0.46) target price on shares of Allergy Therapeutics in a research note on Monday, March 18th.

Shares of AGY opened at GBX 13.25 ($0.17) on Thursday. The company has a 50 day moving average of GBX 13.69. The stock has a market capitalization of $84.29 million and a P/E ratio of -26.50. The company has a debt-to-equity ratio of 6.20, a current ratio of 3.74 and a quick ratio of 3.08. Allergy Therapeutics has a 1-year low of GBX 8 ($0.10) and a 1-year high of GBX 28.95 ($0.38).

Allergy Therapeutics Company Profile

Allergy Therapeutics plc engages in the research and development of allergy treatments. It sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees. The company's products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, and Venomil.

Featured Article: Understanding Average Daily Trade Volume

Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report